ROSSI, MARIO Statistiche
ROSSI, MARIO
A New Threat to Dopamine Neurons: The Downside of Artificial Light
2020-01-01 Fasciani, I.; Petragnano, F.; Aloisi, G.; Marampon, F.; Rossi, M.; Coppolino, M. F.; Rossi, R.; Longoni, B.; Scarselli, M.; Maggio, R.
Distinctive binding properties of the negative allosteric modulator, [3H]SB269,652, at recombinant dopamine D3 receptors
2018-01-01 Fasciani, Irene; Pietrantoni, Ilaria; Rossi, Mario; Mannoury la Cour, Clotilde; Aloisi, Gabriella; Marampon, Francesco; Scarselli, Marco; Millan, Mark J; Maggio, Roberto
Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences
2018-01-01 Aringhieri, Stefano; Carli, Marco; Kolachalam, Shivakumar; Verdesca, Valeria; Cini, Enrico; Rossi, Mario; Mccormick, Peter J.; Corsini, Giovanni U.; Maggio, Roberto; Scarselli, Marco
Dichlorodiphenyltrichloroethane (DDT) induced extracellular vesicle formation: a potential role in organochlorine increased risk of Parkinson's disease
2017-01-01 Rossi, Mario; Scarselli, Marco; Fasciani, Irene; Maggio, Roberto; Giorgi, Franco
Historical Perspectives: From Monomers to Dimers and Beyond, an Exciting Journey in the World of G Protein-Coupled Receptors
2017-01-01 Rossi, Mario; Maggio, Roberto; Fasciani, Irene; Scarselli, Marco
The First Negative Allosteric Modulator for Dopamine D2 and D3 Receptors SB269652 May Lead to a New Generation of Antipsychotic Drugs
2017-01-01 Rossi, Mario; Fasciani, Irene; Marampon, Francesco; Maggio, Roberto; Scarselli, Marco
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A New Threat to Dopamine Neurons: The Downside of Artificial Light | 1-gen-2020 | Fasciani, I.; Petragnano, F.; Aloisi, G.; Marampon, F.; Rossi, M.; Coppolino, M. F.; Rossi, R.; Longoni, B.; Scarselli, M.; Maggio, R. | |
| Distinctive binding properties of the negative allosteric modulator, [3H]SB269,652, at recombinant dopamine D3 receptors | 1-gen-2018 | Fasciani, Irene; Pietrantoni, Ilaria; Rossi, Mario; Mannoury la Cour, Clotilde; Aloisi, Gabriella; Marampon, Francesco; Scarselli, Marco; Millan, Mark J; Maggio, Roberto | |
| Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences | 1-gen-2018 | Aringhieri, Stefano; Carli, Marco; Kolachalam, Shivakumar; Verdesca, Valeria; Cini, Enrico; Rossi, Mario; Mccormick, Peter J.; Corsini, Giovanni U.; Maggio, Roberto; Scarselli, Marco | |
| Dichlorodiphenyltrichloroethane (DDT) induced extracellular vesicle formation: a potential role in organochlorine increased risk of Parkinson's disease | 1-gen-2017 | Rossi, Mario; Scarselli, Marco; Fasciani, Irene; Maggio, Roberto; Giorgi, Franco | |
| Historical Perspectives: From Monomers to Dimers and Beyond, an Exciting Journey in the World of G Protein-Coupled Receptors | 1-gen-2017 | Rossi, Mario; Maggio, Roberto; Fasciani, Irene; Scarselli, Marco | |
| The First Negative Allosteric Modulator for Dopamine D2 and D3 Receptors SB269652 May Lead to a New Generation of Antipsychotic Drugs | 1-gen-2017 | Rossi, Mario; Fasciani, Irene; Marampon, Francesco; Maggio, Roberto; Scarselli, Marco |